{"created":"2014-08-13T18:09:39+00:00","modified":"2015-05-15T13:23:31+00:00","valid":{"from":"2013-04-11T08:08:31+00:00","to":"3013-04-11T08:08:31+00:00"},"hreflang":"en","tags":["APM","APM_Episode"],"byline":"Jeremy Hobson, David Brancaccio, Mark Gregory, Peter O'Dowd, Adrienne Hill and Diane Swonk","guid":"ddec3870-8cd1-420e-8eec-ee124145b0b7","teaser":"<a href=\"http://www.biogenidec.com/\" target=\"_blank\">Biogen Idec</a>, a Massachusetts-based biotech company, is hoping its new multiple sclerosis drug <a href=\"http://www.tecfidera.com/index.html?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=Branded+-+Tecfidera&amp;utm_term=tecfidera&amp;utm_content=General%7Cmkwid%7CsizwNqPjR%7Cpcrid%7C20563887307\" target=\"_blank\">Tecfidera</a> will eventually bring in the hundreds of millions of dollars it cost to develop -- at least before a generic comes along and copies it. CEO George Scangos discusses his company's development process and pricing strategy. A new report from the research firm IDC says personal computer sales are falling fast all around the world. And in Phoenix, Arizona, new signs of a real estate bubble are emerging.","published":"2013-04-11T08:08:31+00:00","contentencoded":"<div class=\"barn-cleaned\"></div>","description":"<a href=\"http://www.biogenidec.com/\" target=\"_blank\">Biogen Idec</a>, a Massachusetts-based biotech company, is hoping its new multiple sclerosis drug <a href=\"http://www.tecfidera.com/index.html?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=Branded+-+Tecfidera&amp;utm_term=tecfidera&amp;utm_content=General%7Cmkwid%7CsizwNqPjR%7Cpcrid%7C20563887307\" target=\"_blank\">Tecfidera</a> will eventually bring in the hundreds of millions of dollars it cost to develop -- at least before a generic comes along and copies it. CEO George Scangos discusses his company's development process and pricing strategy. A new report from the research firm IDC says personal computer sales are falling fast all around the world. And in Phoenix, Arizona, new signs of a real estate bubble are emerging.","itags":["Marketplace Morning Report for Thursday, April 11, 2013","Marketplace","Marketplace Morning Report","PMP:Marketplace_PMP","ddec38708cd120e6eec0ee124145b0b7"],"contenttemplated":"[]","title":"Marketplace Morning Report for Thursday, April 11, 2013","audio":[{"href":"http://www.marketplace.org/sites/default/files/styles/primary-image-610x340/public/163683126.jpg?itok=-iN7xGJD","meta":{"height":"340","width":"610","crop":"primary"},"type":"image/jpeg"},{"type":"audio/mpeg","href":"http://play.publicradio.org/pmp/d/podcast/marketplace/morning_report/2013/04/11/marketplace_morning_report0550_20130411_64.mp3","meta":{"duration":480,"duration_hms":"00:08:00","api":{"href":"http://api.publicradio.org/audio/v2?ref=pmp&id=apm-audio:/marketplace/morning_report/2013/04/11/marketplace_morning_report0550_20130411","type":"application/json"}},"format":"MP3"},{"type":"audio/mpeg","href":"http://play.publicradio.org/pmp/d/podcast/marketplace/morning_report/2013/04/11/marketplace_morning_report_podcast_20130411_64.mp3","meta":{"duration_hms":"00:07:11","api":{"href":"http://api.publicradio.org/audio/v2?ref=pmp&id=apm-audio:/marketplace/morning_report/2013/04/11/marketplace_morning_report_podcast_20130411","type":"application/json"},"duration":431},"format":"MP3"}]}